Open | - |
Close | - |
Volume / Avg. | 859.000 / 1.760M |
Day Range | - - - |
52 Wk Range | 0.257 - 6.800 |
Market Cap | $15.719M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 2.08% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Redhill Biopharma (NASDAQ: RDHL) through any online brokerage.
Other companies in Redhill Biopharma’s space includes: Cingulate (NASDAQ:CING), Iterum Therapeutics (NASDAQ:ITRM), Onconova Therapeutics (NASDAQ:ONTX), Cocrystal Pharma (NASDAQ:COCP) and Kiora Pharmaceuticals (NASDAQ:KPRX).
The latest price target for Redhill Biopharma (NASDAQ: RDHL) was reported by HC Wainwright & Co. on Wednesday, September 15, 2021. The analyst firm set a price target for 21.00 expecting RDHL to rise to within 12 months (a possible 3868.25% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Redhill Biopharma (NASDAQ: RDHL) is $0.5292 last updated Today at March 19, 2024 at 4:19 AM EDT.
There are no upcoming dividends for Redhill Biopharma.
Redhill Biopharma’s Q1 earnings are confirmed for Monday, June 10, 2024.
There is no upcoming split for Redhill Biopharma.
Redhill Biopharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.